These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22172906)

  • 1. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.
    Katz AW; Chawla S; Qu Z; Kashyap R; Milano MT; Hezel AF
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):895-900. PubMed ID: 22172906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
    Sandroussi C; Dawson LA; Lee M; Guindi M; Fischer S; Ghanekar A; Cattral MS; McGilvray ID; Levy GA; Renner E; Greig PD; Grant DR
    Transpl Int; 2010 Mar; 23(3):299-306. PubMed ID: 19843294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
    O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
    Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
    Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
    Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
    Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
    Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series.
    Wang YF; Dai YH; Lin CS; Chang HC; Shen PC; Yang JF; Hsiang CW; Lo CH; Huang WY
    Radiat Oncol; 2021 Jan; 16(1):15. PubMed ID: 33446231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
    Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L
    Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
    Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection prior to liver transplantation for hepatocellular carcinoma.
    Belghiti J; Cortes A; Abdalla EK; Régimbeau JM; Prakash K; Durand F; Sommacale D; Dondero F; Lesurtel M; Sauvanet A; Farges O; Kianmanesh R
    Ann Surg; 2003 Dec; 238(6):885-92; discussion 892-3. PubMed ID: 14631225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.